Anne Mobley Butler, PhD, MS
Instructor in Medicine
- BS - Neuroscience & Behavioral Biology: Emory University, Atlanta GA (2003)
- MS - Epidemiology: Harvard School of Public Health (2006)
- PhD - Epidemiology: Gillings School of Global Public Health, University of North Carolina at Chapel Hill (2014)
- Postdoctoral Fellowship - Epidemiology: Gillings School of Global Public Health, University of North Carolina at Chapel Hill (2015-2017)
Dr. Butler’s research involves the application of epidemiologic study designs and analytic methods to highly detailed, clinical and administrative data that are captured on patients as part of routine clinical care. Her pharmacoepidemiology research focuses on the treatment and prevention of common infections, including antibiotic and vaccine utilization, effectiveness, safety, and related outcomes. Dr. Butler’s work utilizes data from various national databases including US commercial claims, Medicare, Medicaid, United States Renal Database System, Flatiron, and other clinical cohorts. Given that various patient populations are rarely included in clinical trials, results generated from these studies provide much needed evidence to inform decisions related to clinical practice, health policy, and quality improvement interventions. Dr. Butler has a secondary appointment in the Division of Public Health Sciences at Washington University School of Medicine.
Butler AM, Layton JB, Li D, Hudgens MG, Boggess KA, McGrath LJ, Becker-Dreps S. Predictors of low uptake of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis immunization in privately-insured women in the United States. Obstetrics and Gynecology 2017; 129(4):629-637.
Layton JB, Butler AM, Li D, Boggess KA, Weber DJ, McGrath LJ, Becker-Dreps. Prenatal pertussis immunization and risk of maternal and newborn adverse events. Vaccine 2017 Jul 24;35(33):4072-4078. doi: 10.1016/j.vaccine.2017.06.071. Epub 2017 Jun 29.
Butler AM, Olshan AF, Kshirsagar AV, Wang L, Edwards JK, Nielsen ME, Wheeler SB, Brookhart MA. Cancer incidence among US Medicare end-stage renal disease patients receiving hemodialysis, 1996-2009. American Journal of Kidney Diseases 2015; 65(5):763-772.
Butler AM, Olsen MA, Merz LR, Guth RM, Woeltje KF, Camins BC, Fraser VJ. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infection Control and Hospital Epidemiology 2010; 31:28-35.